Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease
Clinical trial NCT03422627 · TERMINATED
Trial details
- NCT number
- NCT03422627
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-27
- Primary completion
- 2022-10-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.